報價延遲最少15分鐘:2025/07/22 13:33 EDT
常規時段
|
|
|
|
|
||||||||||||
|
|
|
|
|
2.2084 
|
|
|
| 價值評估 |
|
盈利(現時/預測)
-0.92/--
|
|
企業價值
74.49M
|
| 資產負債 |
|
每股賬面淨值
2.30
|
| 現金流量 |
|
現金流量率
--
|
| 損益表 |
|
收益
637.00K
|
|
每股收益
0.01
|
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
報價延遲最少15分鐘：2025/07/22 13:33 EDT
同行比較之報價最少15分鐘延遲
|
業務概覽
|
|||
| Rafael Holdings Inc is a holding company with interests in clinical and early-stage pharmaceutical companies. Its primary focus is to expand its investment portfolio through opportunistic investments including therapeutics, which address high unmet medical needs. Through the companies it has invested in, the company is focused on; developing Trappsol Cyclo its clinical program, developing instruments to advance minimally invasive surgeries, preclinical cancer metabolism research operations, and developing pharmaceutical-grade technology Unlokt for third-party cannabis manufacturers. It also holds and manages commercial real estate assets in Jerusalem, Israel. The company's reportable segments are; Infusion Technology, which derives maximum revenue, Healthcare, and Real Estate. |
